Andrew Albert, MD, MPH

Andrew is a highly accomplished executive clinician with 20 years of clinical and leadership experience in growing a section of Gastroenterology into a multidisciplinary Digestive Health Institute with greater than 20% growth in procedural volume in 12 months. He is board-certified in Gastroenterology and holds a Master’s degree in Public Health from the George Washington University School of Medicine, utilizing strong leadership skills, clear communication, and public health strategy to promote health improvement and disease prevention.

Andrew currently serves as the Medical Director with a recent promotion to executive leadership at Advocate Illinois Masonic Medical Center as Medical Staff Secretary/Treasurer. He has also been a distinct leader with the American Cancer Society Hospital and Health System Workgroup; establishing best practices in Colorectal Cancer Screening nationally.

Andrew is entrepreneurial with patient advocacy; achieving statewide recognition as one of the 20 Most Inspiring Chicagoans for grassroots efforts in Chicago. He also cofounded “Fibroblast” (acquired by Cerner Technology) to facilitate efficient, quality care to patients, particularly in the ACO environment.

As Andrew looks forward to the future, he wants to use his depth and breadth of experience to impact greater positive outcomes in population health, hospital and hospital system strategy, and program development.

José Perea, MD

Dr. José Perea is a Consultant Colorectal Surgeon and Associate Professor in the Surgery Department at Fundación Jiménez Díaz University Hospital, Madrid, Spain. Dr. Perea’s clinical and research interests focus on surgery, gastroenterology and oncology, and in particular, understanding the basis of colorectal cancers with differential phenotypes. He coordinates a multicenter multidisciplinary group within Spain, as well as international collaborations, focused on early-onset colorectal cancer and multiple primary colorectal cancers.  Dr. Perea received his medical and surgery degree from the Complutense University of Madrid, his specialist degree in general and gastroenterological surgery from the General University Hospital Gregorio Marañón, Madrid, and his PhD (cum laude) from the University of Salamanca.  He completed a specialization in clinical research Methodology at the National School of Health, Carlos III Institute, Madrid, and a master of molecular oncology degree from the Spanish National Oncological Research Center (CNIO).   Dr. Perea is a member of the scientific committee for the Spanish Society of Coloproctology.

Judy Yee, MD, FACR

Dr. Yee is Professor and University Chair of Radiology at Montefiore Medical Center and the Albert Einstein College of Medicine. Prior to this role she was the Vice-Chair of Radiology and Biomedical Imaging at the University of California, San Francisco. She was also Director of the 3D Imaging Lab at UCSF and Chief of Radiology at the San Francisco VA. In these roles Dr. Yee developed significant experience in building state-of-the-art Radiology Departments, starting new initiatives and developing innovative programs.

Dr. Yee is an accomplished abdominal and gastrointestinal radiologist with a research focus on CT Colonography (Virtual Colonoscopy), as well as bowel, liver and pancreatic imaging using CT and MR. She has published multiple landmark studies in the field of CT Colonography and is widely considered a pioneer in the field. CT Colonography is now used for colorectal cancer screening and diagnosis around the world.  Her publications include over 130 peer-reviewed articles, 23 book chapters, and over 140 abstracts.

Dr. Yee is an established leader and served on the Board of the Society of Abdominal Radiology (SAR) and was the President of SAR from 2015-2016. She currently serves as Chair of the American College of Radiology Colon Cancer Committee and Chair of the RSNA Gastrointestinal Refresher Course Program. She serves on the Editorial Boards of Abdominal Radiology and JCAT and has also served on the Editorial Boards of Radiology, RadioGraphics and AJR. She is a member of the Board and Co-Chair of the Diversity and Inclusion Committee for the New York State Radiologic Society and a member of the ACR Body Commission.

Dr. Yee provides many invited lectures nationally and internationally. She is a well-respected educator, having instructed and mentored multiple trainees. Dr. Yee is the recipient of numerous awards including the Excellence in Teaching Award from the Academy of Medical Educators, Visiting Professorship Award from the Society of Abdominal Radiologists, Best Speaker Award of the American Roentgen Ray Society, and the University of California, San Francisco Outstanding Faculty Mentoring Award. She is recently awarded 2019 Honorary Fellow of the European Society of Gastrointestinal and Abdominal Radiology (ESGAR), the sole recipient from the United States to receive this honor in 2019 in recognition of her global contributions to the field. Dr. Yee is also the first woman to receive this honor in 30 years.

Kimmie Ng, MD, NPH

Dr. Kimmie Ng has the expertise, training, leadership, and resources necessary to serve as Faculty in this program. She is a board-certified medical oncologist with MD and MPH degrees who specializes in the treatment and investigation of gastrointestinal malignancies. Dr. Ng’s research program focuses on the identification of dietary, molecular, and genetic predictors of improved survival in colorectal cancer (CRC) patients. She has published extensively on the relationship between vitamin D status and survival of patients with CRC, and is now translating her findings into randomized clinical trials for patients. She has received multiple grants to support her work, including K07 and R01 awards evaluating vitamin D and inflammation in CRC, and served as Co-Project Leader of Project 2 in the Dana-Farber/Harvard Cancer Center (DF/HCC) SPORE in Gastrointestinal Cancer.

Matthew A. Weissman, MD, MBA

Dr. Matthew A. Weissman is the Site Chair of the Department of Medicine at Mount Sinai Beth Israel Hospital, New York Eye and Ear Infirmary, and Mount Sinai Downtown and an Associate Professor in Internal Medicine and Pediatrics at the Icahn School of Medicine at Mount Sinai.  In addition to maintaining an active primary care practice, he is responsible for the clinical, educational, and research activities of the Department, including oversight of more than 175 employed faculty and 120 medical residents and postdoctoral fellows.

Previously, Dr. Weissman was the Chief Medical Officer of Community Healthcare Network (CHN), a major network of Federally Qualified Health Centers (FQHC) in New York City.   Under his leadership, CHN expanded access to and quality of care, including winning the Health Center Quality Leaders Award three years in a row from the Health Resources and Services Administration (HRSA), an agency of the U.S. Department of Health and Human Services. Following the passing of CHN’s President and CEO in May 2014 and until January 2015, Dr. Weissman served as CHN’s Acting President and CEO helping to create the first Nurse Practitioner fellowship program in New York State and one of the first in the country.

Dr. Weissman received his undergraduate degree in Economics from Harvard University magna cum laude and a Medical Doctorate and Masters in Business Administration in Health Management from Tufts University. He completed his residency and chief residency at Mount Sinai Medical Center in New York and is Board Certified in both Internal Medicine and Pediatrics.  He currently co-chairs the New York City Department of Health and Mental Hygiene’s Citywide Colorectal Cancer Control Coalition (C5). His primary interests are the transition from pediatric to adult care, leveraging technology to streamline delivery and improve access to and quality of care, and training the next generation of physicians and medical leaders.

Richard Fahrer, EAO-CRC

Richard has over 17 years’ experience in healthcare marketing.   He holds the title of Oncology Marketing Director, Patient Solutions; and leads the marketing efforts for Pfizer’s US Oncology portfolio of patient services,  including their signature program, Pfizer Oncology Together.

Prior to joining Pfizer in 2012, he held customer strategy and analytics roles at Saatchi & Saatchi Wellness and Patients & Purpose. Richard has successfully launched a myriad of engagement programs for Patients, Caregivers, Nurses and Physicians within the US and Globally.

Originally from Freeport, Long Island, he now resides in West Orange, New Jersey, with his wife, Allegra, and two sons, Shepard (6) and Hartley (3).

Susan K. Peterson, PhD, MPH

Dr. Susan Peterson is Professor of Behavioral Science at MD Anderson Cancer Center.  Her research focuses on psychosocial and behavioral outcomes of genetic testing for hereditary cancer syndromes in cancer survivors and their families, as well as the integration of genetic services into general oncology care. Her work centers on cancer survivors’ and families’ decision-making about genetic testing and receiving genetic test results, and the subsequent psychological and behavioral impact of those decisions, including the impact on quality of life and related factors. A cross-cutting theme of Dr. Peterson’s research is the development and evaluation of novel, e-Health interventions for populations at risk for hereditary cancer and cancer survivors, including internet- and game-based behavior change interventions for adolescents and young adults. Dr. Peterson also leads research to develop and evaluate novel sensor-based and mobile technology applications for behavioral assessment and intervention.

Zsofia Stadler, MD

Dr. Stadler is the Clinical Director of the Clinical Genetics Service with a primary appointment in Clinical Genetics and a secondary appointment in the Gastrointestinal Medical Oncology Service at Memorial Sloan-Kettering Cancer Center. She completed her medical training at Cornell University followed by residency at the Brigham and Women’s Hospital at Harvard University. For medical oncology fellowship, she remained at Harvard University where her research focused on clinical cancer genetics and hereditary cancer syndromes. Dr. Stadler joined MSKCC in 2008, where she is now an Associate Attending Physician and is also appointed as an Associate Professor of Medicine at Weill Cornell Medical College. Her clinical focus is on the diagnosis, treatment, and management of patients and families with an inherited genetic predisposition to colorectal and other gastrointestinal cancers. Her research interests focus on the identification of new cancer susceptibility genes through the use of genomic technologies and the development of novel approaches to cancer screening and prevention in high-risk families. She has been the PI of numerous projects with funding from the National Institute of Health, Damon Runyon Cancer Research Foundation, Cycle for Survival, Starr Cancer Consortium, and the Romeo Milio Lynch Syndrome Foundation. She was recently appointed the Associate Director of the Precision Interception and Prevention Program at MSKCC. She has published and lectured internationally on gastrointestinal cancer genetic syndromes, serves as Co-Chair of the Genetics and Genomics Committee of the American Society of Clinical Oncology (ASCO) and was selected for the New York Magazine:Top Doctors award in 2019.